Position in CELC
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$10,843,300
-$1,125,500 QoQ
Shares Held
95,000
-20.8% QoQ
Ownership
0.195%
of shares outstanding
% of Portfolio
1.92%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CELC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Patient Square Capital LP holds $541,382,392 across 26 Biotechnology names. CELC ranks #14 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
8,166,047 | $226,199,501 | |
| 2 | ARGX |
Argenx SE
|
36,718 | $26,813,319 | |
| 3 | INSM |
INSMED Inc
|
157,500 | $25,754,400 | |
| 4 | ONC |
BeOne Medicines Ltd.
|
80,542 | $23,918,557 | |
| 5 | COGT |
Cogent Biosciences, Inc.
|
596,000 | $22,940,040 | |
| 6 | MIRM |
Mirum Pharmaceuticals, Inc.
|
230,000 | $21,247,400 | |
| 7 | BLTE |
Belite Bio, Inc
|
116,684 | $18,604,096 | |
| 8 | LEGN |
Legend Biotech Corp
|
990,000 | $17,909,100 |
All Filings in CELC
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,843,300 | 95,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $11,968,800 | 120,000 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $4,940,000 | 100,000 | Shares | Sole | 2025-11-10 | |
| No filing history on record for this holder in this stock. | ||||||